CDK7 and head and neck squamous cell carcinoma: In particular, the linkage of CDK7 and immunotherapy might be of great interest for prospective research since checkpoint inhibition is becoming increasingly important in HNSCC treatment but mechanisms to boost therapy response remain poorly understood.